Fact CheckerSign in

NCT05977881Completed

Substance Checking Outreach and Pre-Exposure Prophylaxis (PrEP) Engagement Study

Impact of a Novel HIV Peer Navigation and Overdose Prevention Intervention on Engagement in the HIV Prevention and Treatment Cascade

Source: ClinicalTrials.gov · Last updated 14 May 2026

Brief summary (registry, in English)

Through the proposed Substance Checking Outreach and Pre-Exposure Prophylaxis (PrEP) Engagement (SCOPE) study, the investigators will design and evaluate an overdose prevention and HIV prevention study among people who use drugs (PWUD). Specifically, SCOPE will provide access to drug-checking services for PWUD to better understand the contents of the drug supply, in combination with PrEP for those who are HIV-, to both reduce overdose and HIV among PWUD in Baltimore City.

Status (registry)
Completed
Study type
Interventional
Enrollment
493 (actual)
First submitted
27 Jul 2023
Start date
28 Jul 2023
Primary completion date
1 May 2026
Lead sponsor
Johns Hopkins Bloomberg School of Public Health
Diseases
HIV
NCT number
NCT05977881

What you commit to

  • Study type: Interventional
  • Participants enrolled: 493
  • From 28 Jul 2023 to the primary completion date, 1 May 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Age

  • Determined to be too high or drunk or cognitively impaired, less than 18 years of age

Other

  • unwilling to provide all required biological specimens (Phase 3 only)
  • unwilling/unable to give consent

Who the study is looking for

  • 18 years or older,
  • self-reports having used illicit stimulants or opioids at least once in the past 3 months,
  • self-reports being HIV negative
  • reports injection drug use in the past 6 months OR reports at least one of the following indicators of sexual HIV risk exposure in the past 6 months:
    • Sexually Transmitted Infection (STI) diagnosis in the past 6 months
    • "Condom-less" vaginal or anal sex in the past 6 months
  • Willing to provide a urine sample for urine drug screening of substances
  • Willing to undergo rapid HIV testing
  • Willing to undergo STI testing

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Johns Hopkins School of Public Health
Coordinator of this site? Confirm its status
BaltimoreUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.